Clomid vs Enclomiphene 2026: Clinical Comparison for Men

Clomid (clomiphene citrate) and enclomiphene sound almost interchangeable, and in most consumer articles they’re treated that way. Clinically they aren’t. Enclomiphene is one of the two isomers that make up clomiphene — the active one. Clomiphene the mixed product also contains zuclomiphene, which is responsible for almost every meaningful side effect patients complain about.

This is a straight comparison of the two for men with low testosterone. Chemistry, mechanism, dosing, side effect profile, cost, and why the telehealth hormone optimization space has largely moved to enclomiphene-only protocols. Talk to a licensed provider before starting either — this is clinical comparison, not medical advice.

The Short Version

Property	Clomid (clomiphene)	Enclomiphene
What it is	Racemic mix: 62% enclomiphene + 38% zuclomiphene	Pure trans-isomer (enclomiphene only)
Mechanism	SERM — blocks estrogen feedback, increases LH/FSH, raises T	Same, but without zuclomiphene’s side effects
Typical dose	25mg every other day or daily	12.5–25mg daily
Side effects	Visual disturbances, mood issues, gyno risk	Cleaner profile, fewer side effects
FDA status	Approved for female infertility; off-label for men	Not FDA-approved; available via compounding
Cost (US, cash)	~$20–$40/month generic	~$40–$90/month compounded
Fertility preserved	Yes	Yes

If you’re choosing between them today and cost isn’t the constraint, enclomiphene is usually preferred. The clinical reason is specific and worth understanding.

The Chemistry

Clomiphene citrate is a 1:1.6 racemic mixture of two stereoisomers:

• Enclomiphene (trans-clomiphene): ~62% of the mixture. Pure estrogen antagonist. Shorter half-life (~10 hours).
• Zuclomiphene (cis-clomiphene): ~38% of the mixture. Weak estrogen agonist — actually binds and activates estrogen receptors rather than blocking them. Much longer half-life (~30+ days, accumulates in tissue).

When you take clomid, you’re getting both. When you take enclomiphene, you’re only getting the trans-isomer.

This distinction matters because of zuclomiphene’s accumulation. Over weeks of daily clomid dosing, zuclomiphene builds up in adipose tissue. It’s still measurable in blood months after discontinuation. That accumulated zuclomiphene, acting as a weak estrogen agonist, is what drives most of the side effect profile men associate with “clomid for low T.”

Mechanism (Both Drugs)

Clomiphene and enclomiphene are selective estrogen receptor modulators (SERMs). The mechanism is identical: they bind to estrogen receptors in the hypothalamus, blocking estrogen’s negative feedback signal. The hypothalamus interprets the reduced estrogen signal as “not enough estrogen → stimulate more testosterone production” and ramps up GnRH. Higher GnRH → higher LH and FSH from the pituitary → more testosterone and sperm production from the testes.

The result: your body makes more of its own testosterone. Unlike TRT, which shuts down natural production, SERMs preserve and actually upregulate the HPT axis. This is why they’re used for:

• Younger men with hypogonadism who want to preserve fertility
• Secondary hypogonadism where the problem is signaling rather than testicular failure
• TRT-adjacent use — some men prefer SERMs over TRT for the non-suppressive mechanism
• Post-TRT HPT axis restart protocols

Enclomiphene executes this mechanism cleanly. Clomiphene adds zuclomiphene’s partial estrogen agonism to the mix, which partially works against the intended effect and drives side effects.

Effect on Testosterone Levels

Both drugs reliably raise testosterone in men with secondary hypogonadism. Typical clinical results:

• Baseline testosterone in candidates: 200–350 ng/dL
• Post-treatment (6–12 weeks): 500–800 ng/dL, sometimes higher
• Increase: typically 100–150% over baseline

Head-to-head, enclomiphene and clomiphene produce similar total testosterone increases. The difference isn’t in how high T goes — it’s in how tolerable the ride is.

Side Effect Profile — Where The Drugs Diverge

This is the clinically meaningful difference.

Clomiphene (Clomid) side effects in men:

• Visual disturbances — scintillating scotomas, blurred vision, light sensitivity. Reported in 1–5% of users. Usually resolves on discontinuation but can persist in rare cases.
• Mood issues — depression, irritability, emotional lability. More common than visual effects. Attributed to zuclomiphene’s estrogenic activity.
• Gynecomastia risk — estrogen agonism at breast tissue can cause tender breast tissue or visible development, especially in men with higher baseline estradiol.
• Fatigue — paradoxical in a drug that raises testosterone; likely zuclomiphene-driven.
• Reduced exercise capacity in some studies, again zuclomiphene-attributed.

Enclomiphene side effects:

• Headache — 3–8% of users, usually mild and transient
• Nausea — occasional, usually early in treatment
• Hot flashes — uncommon but reported
• Mood effects — substantially rarer than with clomid
• Visual effects — essentially absent in clinical trials

The half-life difference drives most of this. Enclomiphene clears the body in 1–2 days. Zuclomiphene hangs around for weeks. If you stop clomid because of side effects, you’re still subject to zuclomiphene’s effects for a month or more. Stop enclomiphene and you’re off it in days.

Typical Dosing

Clomid: 25mg every other day is the most common starting protocol for men. Some clinicians do 25mg daily. Higher doses (50mg daily) are generally not more effective and increase side effects.

Enclomiphene: 12.5mg daily is common starting dose. Can increase to 25mg daily if response is insufficient. The lower milligram dose reflects that you’re getting pure active isomer rather than a 62% active mixture.

Both require morning dosing for best effect and should be taken consistently. Treatment duration is typically 3–6 months with labs at 6–8 weeks to check response.

FDA and Availability

Clomid (clomiphene citrate): FDA-approved for female infertility since 1967. Prescribed off-label for male hypogonadism — this is legal and common, but it’s not an FDA-approved use. Available as a cheap generic at almost any pharmacy.

Enclomiphene citrate: Developed for male hypogonadism specifically. Completed Phase 3 trials but not currently FDA-approved as a standalone product. Available through compounding pharmacies when prescribed by a licensed physician. The compounding path is legal and well-established in telehealth; it does mean quality and dosing consistency depends on the pharmacy.

This is why most telehealth clinics that prescribe enclomiphene use specific named compounding pharmacies — to maintain quality control.

Cost Comparison

Clomid: $10–$40/month for a generic 30-day supply at retail pharmacies with or without insurance. One of the cheapest prescriptions available. Insurance sometimes covers it when prescribed for infertility; off-label use for low T is typically cash-pay.

Enclomiphene: $40–$90/month through compounding pharmacies. Prices vary by pharmacy and by clinic model — telehealth clinics often bundle into monthly memberships that include the medication.

The 2–4x price difference is the main argument for clomid over enclomiphene. If budget is the constraint and you tolerate clomid’s side effects, clomiphene works. For most men without that constraint, enclomiphene’s cleaner side effect profile is worth the difference.

Fertility Preservation (Both Drugs)

Both clomiphene and enclomiphene preserve and often improve fertility compared to TRT:

• TRT → shuts down LH/FSH → stops spermatogenesis → infertility within weeks to months
• SERMs → increase LH/FSH → maintain or increase spermatogenesis → fertility preserved

This is the primary reason younger men and men planning to have children are steered toward SERMs over TRT when labs allow it. A man with total T of 340 ng/dL who wants kids in the next 2–3 years is usually better served by enclomiphene than by TRT, even if TRT would raise his testosterone faster.

When Clomid Still Makes Sense

Despite enclomiphene’s advantages, clomiphene citrate still has its place:

• Cost-constrained patients — $20/month vs $60–$90/month matters for some
• No local compounding pharmacy access — clomid is at every chain pharmacy; enclomiphene requires compounding
• Tolerating the side effects fine — some men take clomid for years without visual or mood issues. If you’re one of them, there’s no clinical reason to switch.
• Insurance covers clomid for infertility — if you have a legitimate fertility indication, insurance coverage may make clomid substantially cheaper than cash-pay enclomiphene.

When Enclomiphene Is Clearly Better

• Sensitive to side effects — if clomid gave you visual disturbances, mood issues, or gyno, switching to enclomiphene often resolves them entirely
• Long-term use planned — zuclomiphene accumulation over years of daily clomid raises more safety questions than enclomiphene’s cleaner clearance profile
• Fertility-focused with good lab access — enclomiphene’s cleaner estrogen receptor action may theoretically be better for semen parameters (limited head-to-head data)
• Prescriber uses a trusted compounding pharmacy — quality control concerns vanish when the supply chain is known

The Honest Answer

For most men choosing today in 2026, with access to a telehealth clinic that uses a reputable compounding pharmacy, enclomiphene is the better drug. The side effect advantage is real, the mechanism is cleaner, and the monthly price difference is modest relative to the clinical benefit. Clomid remains a legitimate option — it’s cheap, widely available, and works — but it’s no longer the default first choice it was a decade ago.

Neither drug replaces TRT for men with primary hypogonadism (testicular failure), because SERMs require functioning Leydig cells to respond to LH/FSH signaling. If your testes can’t make testosterone regardless of signaling, TRT is the answer, not SERMs.

Talk to a licensed provider about which is appropriate for you. Get full labs first — total T, free T, LH, FSH, estradiol, SHBG, semen analysis if fertility matters. The drug choice follows the lab picture, not the other way around.